Singapore markets closed
Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,405.66 +470.90 (+1.24%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,144.13 -2.90 (-0.04%) Bitcoin USD
60,153.62 -2,568.84 (-4.10%) CMC Crypto 200
1,279.24 -59.83 (-4.46%)
Bio-Rad Laboratories, Inc. (BIO)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 03:43PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 7.92B |
| Enterprise value | 7.72B |
| Trailing P/E | N/A |
| Forward P/E | 24.88 |
| PEG ratio (5-yr expected) | 1.07 |
| Price/sales (ttm) | 3.03 |
| Price/book (mrq) | 0.90 |
| Enterprise value/revenue | 2.89 |
| Enterprise value/EBITDA | -11.78 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.88 |
| 52-week change 3 | -38.62% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 473.50 |
| 52-week low 3 | 261.59 |
| 50-day moving average 3 | 323.54 |
| 200-day moving average 3 | 336.92 |
Share statistics
| Avg vol (3-month) 3 | 204.71k |
| Avg vol (10-day) 3 | 225.13k |
| Shares outstanding 5 | 23.42M |
| Implied shares outstanding 6 | 28.57M |
| Float 8 | 19.96M |
| % held by insiders 1 | 15.24% |
| % held by institutions 1 | 83.55% |
| Shares short (15 Apr 2024) 4 | 688.47k |
| Short ratio (15 Apr 2024) 4 | 3.77 |
| Short % of float (15 Apr 2024) 4 | 3.86% |
| Short % of shares outstanding (15 Apr 2024) 4 | 2.41% |
| Shares short (prior month 15 Mar 2024) 4 | 579.33k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 2:1 |
| Last split date 3 | 08 Mar 2002 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -23.86% |
| Operating margin (ttm) | 14.24% |
Management effectiveness
| Return on assets (ttm) | 1.77% |
| Return on equity (ttm) | -6.94% |
Income statement
| Revenue (ttm) | 2.67B |
| Revenue per share (ttm) | 91.45 |
| Quarterly revenue growth (yoy) | -6.70% |
| Gross profit (ttm) | N/A |
| EBITDA | 511.6M |
| Net income avi to common (ttm) | -637.32M |
| Diluted EPS (ttm) | -21.81 |
| Quarterly earnings growth (yoy) | -57.80% |
Balance sheet
| Total cash (mrq) | 1.61B |
| Total cash per share (mrq) | 56.35 |
| Total debt (mrq) | 1.41B |
| Total debt/equity (mrq) | 16.08% |
| Current ratio (mrq) | 5.83 |
| Book value per share (mrq) | 306.51 |
Cash flow statement
| Operating cash flow (ttm) | 374.9M |
| Levered free cash flow (ttm) | 170.82M |
© 2024 Yahoo. All rights reserved.